Brief: Toleranzia: 3P Is Expected To Deliver GMP Material For Clinical Study During Q4 2021

Toleranzia AB

25/02/2020 08:10

Feb 25 (Reuters) - Toleranzia AB  TOLE.TE :
    * 3P IS EXPECTED TO DELIVER GMP MATERIAL FOR THE CLINICAL
STUDY
DURING Q4 2021 AND THE STUDY IS EXPECTED TO START DURING 2022

Source text for Eikon:  ID:nWkr9L0yyK 
Further company coverage:  TOLE.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))